Japanese drugmaker Shionogi & Co said on Tuesday it has sold the development and marketing rights for a COVID-19 treatment to California-based biotech BioAge Labs Inc. The company Japanese drugmaker…

Read more »

The post Japan’s Shionogi Sells Coronavirus Drug Rights to U.S. Biotech BioAge appeared first on Hamodia.

In related news:

  1. Coronavirus May Have Spread in Wuhan in August, Harvard Research Shows
  2. Scotland’s Handling of Virus Boosts Support for Independence
  3. Spain to Begin Vaccination Program in January
  4. PMI: U.K. Economy Shrinks as New Lockdown Shuts Services Firms
  5. U.K. Approves Pfizer-BioNTech COVID-19 Vaccine, First in the World